Butler J, Siddiqi TJ, Filippatos G, Ferreira JP, et al. Early Benefit with Empagliflozin in Heart Failure with Preserved Ejection Fraction Insights from the EMPEROR-Preserved Trial. Eur J Heart Fail 2022 Jan 5. doi: 10.1002/ejhf.2420.
PMID: 34989083